Please login to the form below
payer
This page shows the latest payer news and features for those working in and with pharma, biotech and healthcare.
Gilead optimistic about Yescarta deal in UK
This could consolidate Gilead’s advantage in Europe – although payers across the continent will be keen for Novartis to enter the DLBCL fray in order to create price competition.
Latest news
-
Alnylam claims first RNAi approval from FDA for patisiran
Healthcare payers have applauded Alnylam for linking reimbursement to patient outcomes, with Express Scripts saying that the move is “a responsible approach to pricing and patient access in the rare disease
-
Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity
Novo Nordisk is claiming a 14% share of the new-to-brand prescription market with Ozempic, and says “initial feedback from prescribers and payers is positive”in its first-half results
-
Dupixent bounce-back helps stem diabetes declines at Sanofi
the uptick is still slow, rising from 49m in the first quarter despite Sanofi’s efforts to won over US payers, for example offering improved rebates for formulary access.
-
Amgen’s R&D chief Sean Harper retires to seek biotech post
Cholesterol drug Repatha (evolocumab), which has been pegged back by payer resistance, started to gather momentum with a 78% second-quarter gain to $148m, and there were also solid gains for ... payers, which means early performance is hard to gauge.
-
Collaborate to survive
Quality RWD will give companies, clinicians, patients and payers new ways of evaluating treatment options, driving greater transparency and enhancing evidence-based practice. ... Working for the common good in collaboration with clinical and patient
More from news
Approximately 7 fully matching, plus 552 partially matching documents found.
Latest Intelligence
-
The European Medicines Agency: PRIME’d for access?
That could help to overcome issues with the evidence that payers want to see. ... The end result could well be a stand-off between payers and companies on price.
-
Brand teams: why are some smarter than others?
For example, we might revise our assumption to be ‘a corporate presence at congresses influences its attendees towards prescribing a brand when they are in a supportive payer environment’. ... Combining the two would focus congress activity on
-
How behavioural design is transforming the role and impact of life sciences in healthcare
As policy-makers and payers continue to demand better value for money and outcomes, companies across the health ecosystem will increasingly find themselves in the business of delivering health outcomes.
-
Bluebird Bio: on the cusp of a gene therapy revolution
It was also held back by huge bureaucracy around its pricing and reimbursement, and a lack of buy-in from payers in Europe. ... Prasad thinks Bluebird’s commercial model is viable, just as long as it listens to the mood music from payers.
-
The rise of vertical integration in the US payer landscape
The rise of vertical integration in the US payer landscape. Is it a solution to addressing the challenges of the value-based marketplace? ... But how can manufacturers respond to these new customers? PBM within a payer: Anthem.
More from intelligence
Approximately 5 fully matching, plus 192 partially matching documents found.
Latest appointments
-
Open Access Consulting appoints new director
In this role, Hurrell oversaw the team’s market access communications offering, supporting clients in the development of value communications materials with the payer as the ultimate end audience, including core ... value dossiers, payer-focused
-
Claes Buxfeldt joins NDA
He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.
-
Acumen appoints new strategy director
policy makers, patient representatives, media, regulators and payers.
-
VCLS appoints Carole Jones to senior market access role
s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... She said: “I am delighted to be part of an organisation with such an active focus
-
Dr Gopalan Narayanan joins VCLS
interactions with regulators and payers.
More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest from PMHub
-
Drive payer submission readiness for your Phase 2 and 3 products
Created to drive payer submission readiness for Phase 2 and 3 products, the application is the product of 5 years’investment by the independent, specialist consultancy and has been developed in ... This new version of the Healthcheck® late module
-
PRMA Consulting Ltd
Our tailored services include strategic market access, landscape assessments, payer and KOL engagement, value propositions, GVDs, evidence generation, real-world evidence, pricing and reimbursement strategy.
-
Successful brands tell stories
healthcare professionals, carers or payers.
-
Developing advocacy in the pharmaceutical industry.
Good communicators (either as chairs, speakers or both) – potentially to patients, patient organisations and payers, as well as to other healthcare professionals.
-
Trending: using social media to understand your pharma market
Stakeholders for pharmaceutical companies, such as HCPs, patients and payers, are becoming more present on social media and this gives us new data for understanding their needs and preferences.
More from PMHub
Approximately 14 fully matching, plus 144 partially matching documents found.
Featured jobs
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Sudler London - Senior Medical Writer
-
Competitive
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Senior Medical Writer
-
Salary is DOE
-
Associate Scientific Director
-
Salary TBC
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Medical Writers Required - Hertfordshire
-
Competitive
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
-
Sudler London - Account Director
-
Competitive
Subscribe to our email news alerts
- Moving annual total (MAT)
- AZ prepares to file COPD triple, taking on rival GSK
- Key success factor (KSF)
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Teva wins FDA OK for crucial migraine drug
- Gilead targets hep B in half a billion dollar deal with Precision BioSciences
- Lucid limbers up for second annual sports day
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- Hanover Health launches award, Firstlight spins off healthcare arm and more
- J&J files ‘breakthrough’ bladder cancer drug in US
- Boehringer’s Corsico to be new GSK drug dev leader
- More tell, less sell: HCP-centric comms
PMHub
Havas Life Medicom
We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
